• Inicio
  • COVID-19
  • 30-04-2020 Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA: First update.

765Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA: First update

30-04-2020

This first update of the original document is prompted by the recent scientific developments and evolution of the coronavirus 2019 (COVID-19) pandemic and the need to include types of substances of human origin (SoHO) that were not addressed in the first version (e.g. reproductive and some non-reproductive tissues and cells).
This document aims to provide a risk assessment and management options for the safe and sustainable supply of substances of human origin (SoHO) to assist the European Union and European Economic Area (EU/EEA) Member States in responding to the threat posed by the coronavirus disease 2019 (COVID-19) pandemic. Following the rapid spread of COVID-19 in the EU/EEA and worldwide, the European Centre for Disease Prevention and Control (ECDC) has published a set of rapid risk assessments and set out measures on how to maintain the safety and sustainability of SoHO supply. It has also been advocating for EU/EEA Member States to activate pandemic plans to prepare for large outbreaks and community transmission of COVID-19.
 

CONECTA



ACCESOS DIRECTOS


CONTACTA


SOCIEDAD ESPAÑOLA DE INMUNOLOGÍA
logoGPBlancoSecretaría Técnica
Calle Castelló, 128 7ª planta
28006 Madrid (SPAIN)
T. +34 913.836.000 | F. +34 913.023.926
Email: Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.

FUNDACIÓN INNUNOLOGÍA Y SALUD
logoGPBlancoSecretaría Técnica
Calle Castelló, 128 7ª planta
28006 Madrid (SPAIN)
T. +34 913.836.000 | F. +34 913.023.926
Email: Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.


2013 - 2020 ©SEI - Sociedad Española de Inmunología  | Aviso legal